Latest "DeCODE Genetics Inc & ARUP Laboratories" News Stories

08:16 EST 15th November 2018 | BioPortfolio

Here are the most relevant search results for "DeCODE Genetics Inc & ARUP Laboratories" found in our extensive news archives from over 250 global news sources.

More Information about DeCODE Genetics Inc & ARUP Laboratories on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about DeCODE Genetics Inc & ARUP Laboratories for you to read. Along with our medical data and news we also list DeCODE Genetics Inc & ARUP Laboratories Clinical Trials, which are updated daily. BioPortfolio also has a large database of DeCODE Genetics Inc & ARUP Laboratories Companies for you to search.

Showing "DeCODE Genetics ARUP Laboratories" News Articles 1–25 of 3,800+

Thursday 15th November 2018

bluebird bio to Present at the Evercore ISI HealthCONx Conference

bluebird bio, Inc. (Nasdaq: BLUE) today announced that members of the management team will present at the Evercore ISI HealthCONx Conference, Wednesday, November 28, at 4:15 p.m. ET at the Boston Harbor Hotel, Boston. To access the live webcast of bluebird bio’s presentation, please visit the “Events & Presentations” page within the Inve...

FDA Grants Breakthrough Therapy Designation to ADCETRIS® (Brentuximab Vedotin) for Frontline Peripheral T-Cell Lymphomas

-Designation Based on Positive Phase 3 ECHELON-2 Trial Evaluating ADCETRIS in Frontline CD30-Expressing Peripheral T-Cell Lymphomas; Data to be Presented at Upcoming American Society of Hematology Annual Meeting in December- Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that the U.S.

Beam Therapeutics Appoints Carole Ho, M.D., to Board of Directors

Beam Therapeutics, a biotechnology company developing precision genetic medicines through base editing, today announced the appointment of Carole Ho, M.D., Chief Medical Officer and Head of Development at Denali Therapeutics, to the Company’s Board of Directors. “Carole has a remarkable track record in developing new medicines as well a...

Seattle Genetics begins blood cancer trial with SEA-BCMA

SEA-BCMA is an investigational antibody empowered using Seattle Genetics’ proprietary Sugar Engineered Antibody (SEA) technology designed to enhance antibody dependent cellular cytotoxicity. The target of SEA-BCMA, the cell The post Seattle Genetics begins blood cancer trial with SEA-BCMA appeared first on Pharmaceutical Business review.

Interim Report January 1 - September 30, 2018

STOCKHOLM, Nov. 15, 2018 /PRNewswire/ -- RaySearch Laboratories AB (publ) "In the third quarter of 2018, order intake rose 31 percent to SEK 176 M Read more...

Mobidiag Receives Final €4M Tranche of €15M EIB Financing

Mobidiag Ltd., a commercial stage molecular diagnostics company addressing the spread of antimicrobial resistance, announced today that it has received the final €4M tranche of a €15M three-year project secured by the Company from the European Investment Bank Group (EIB) in July 2016. The loan was provided as part of “InnovFin – EU Finance for inno...

Bionik Laboratories Corp BNKL Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryBionik Laboratories Corp Bionik is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company provides rehabilitation technology that senses patient movements and limitations. It provides lower body exoskeleton for wheelchair bound individuals suffering from spinal cord injuries, strokes, and other m...

Wednesday 14th November 2018

Amgen Inc AMGN Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryAmgen Inc Amgen is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncology/hematology, inflammation, bone health, neuroscience and nephrology. The company develops products b...

AusCann set to launch cannabinoid medicine for chronic pain

Medical cannabis company AusCann has announced the successful completion of pilot production of its capsule-based cannabinoid medicine for sufferers of chronic and neuropathic pain, enabling the company to move into commercialised manufacture. The capsules will target the estimated 1.9 million Australians who suffer chronic neuropathic pain through the TGA’s Special Access Scheme, and will also...

INTEGRA named Pipetting Company of the Year

Consulting company Frost & Sullivan has presented INTEGRA Biosciences with the 2018 Global Laboratory Pipetting Company of the Year award, recognising its products as innovative, revolutionary and able to fulfil the needs of customers. INTEGRA offers an extensive range of manual and automated solutions, providing users with flexibility and small-scale automation that can provide high throughp...

Global Milk Market Status and Outlook 20182025 [Report Updated: 14082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...

Pasteur Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryPasteur Institute is a nonprofit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology and chemistry, and virology, among others. It carries out discoveries for prevention, diagno...

Agilent Completes Acquisition of ACEA Biosciences

Acquisition Brings Together Two Pioneers in Cellular Function and Metabolism Measurements Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of ACEA Biosciences Inc. (ACEA), a developer of cutting-edge cell analysis tools, for $250 million in cash. This acquisition brings together two pioneers in cellular function...

Natural GMOs Part 274: Transposons and You.

An interesting fact or discovery that came about from the deeper dives into genetics that more recent technologies have allowed scientists to conduct is that while biological complexity usually coincides with a rise in genome size, it doesn’t necessitate an in

Sanimed & Xenex Deploy Pulsed Xenon UV Disinfection Technology to Battle Superbugs at Victor Babes Hospital in Romania

As hospitals around the world look for strategies to combat healthcare associated infections and antibiotic resistance, Sanimed International and Xenex Disinfection Systems have brought Xenex’s world class room disinfection technology to Romania. Healthcare a

Ambry Genetics Presents Research on the Importance of Reclassifying Disease-Causing Genes at the National Society of Genetic Counselors (NSGC) Annual Meeting

Presentation demonstrates how reclassifying genes and variants may improve medical management ALISO VIEJO, Calif. (PRWEB) November 14, 2018 Researchers from Ambry Genetics (Ambry), a leading clinical genetics testing lab, will present new scientific evidence on gene-disease relationships and how it supports medical management decisions at the National Society of Genetic Counselors (NSGC) Annual M...

Straumann Holding AG STMN Financial and Strategic SWOT Analysis Review [Report Updated: 31102018] Prices from USD $125

Straumann Holding AG STMN Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment ...

Raising Awareness about Early Onset Dementia: “Don’t Leave me now”, Written by Brian Daniels

Fondation IPSEN invites you to attend to a play about caring for people with early onset Alzheimer’s or cerebral dementia A free event open to everyoneNovember 21st, 4 pm The Fondation IPSEN is delighted to invite you to a theatre performance about familial upheavals when a family member is affected by Alzheimer’s disease ...

Essilor International Compagnie Generale d'Optique SA EI Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryEssilor International Compagnie Generale d'Optique SA Essilor designs, manufactures and distributes ophthalmic lenses, sunwear, reading glasses and optics equipment. The company offers a range of corrective lenses for correcting visual disorders such as myopia, hypermetropia and astigmatism. It also manufactures and sells nonprescription reading glasses, sunglasses, equipment, instruments a...

MilliporeSigma Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryMilliporeSigma, formerly SigmaAldrich Corp, a subsidiary of Merck KGaA is a life sciences and technology company which offers biochemical and organic chemical products, kits and services. Its products and services find application in scientific research including genomic and proteomic research; diagnosis of diseases; pharmaceutical development and biotechnology sectors. The company offers i...

Personalis, Inc. to Present at the 3rd Annual NeoAG Summit Boston

Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at the upcoming NeoAG Summit in Boston, MA on Thursday, November 15, 2018 at 4 PM ET. The presentation, entitled “ImmunoID NeXT Platform: Improving Neoantigen Prediction, TME Assessment, and ctDNA Detection for ...

Chong Kun Dang Pharmaceutical Corp 185750 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryChong Kun Dang Pharmaceutical Corp CKD Pharma manufactures, distributes, imports and exports prescription drugs, active pharmaceutical ingredients APIs, overthecounter OTC drugs, health supplements and consumer health products. Its product portfolio includes prescription products for the entire segment and therapeutic classes; vitamins; shampoos; hair colors; aerosols; mat vaporizers and mo...

Ardena: M&A growth fuels HQ expansion

CDMO Ardena has moved into larger headquarters in Gent, Belgium, to âfree up space for additional laboratoriesâ, says CEO.

Bio-Rad and the University of Chicago Win Patent Infringement Case Against 10X Genomics Related to Droplet Microfluidics Technologies

A Federal District Court jury yesterday found that 10X Genomics willfully infringed three United States patents owned by the University of Chicago and exclusively licensed to Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products (NYSE: BIO and BIOb). In awarding Bio-Rad $23.9 million in damages, the jury una...

Seattle Genetics Initiates Phase 1 Clinical Trial of SEA-BCMA for Patients with Relapsed or Refractory Multiple Myeloma

-SEA-BCMA is a Novel Empowered Antibody Targeting BCMA for Multiple Myeloma- -Adds to Seattle Genetics’ Robust Clinical-Stage Development Pipeline across Multiple Hematologic and Solid Tumors- Seattle Genetics, Inc. (Nasdaq:SGEN) announced today dosing of the first

Quick Search


News Quicklinks